Clinical Edge Journal Scan

Better survival among children vs adults with HCC likely attributed to more aggressive surgical management


 

Key clinical point: Improved survival among children vs adults with hepatocellular carcinoma (HCC) despite greater fibrolamellar histology prevalence and positive lymph node number and similar metastasis rates is a likely result of a more aggressive surgical approach.

Major finding: Although children vs adults had a higher prevalence of fibrolamellar HCC (32% vs 9%) and number of positive lymph nodes (35% vs 17%; P = .02) and comparable metastasis rates (30% vs 28%; P = .47), they had significantly better 1-year (81% vs 70%) and 5-year (55% vs 48%) overall survival and surgical intervention (74% vs 62%) rates (all P < .001).

Study details: This study stratified the data of 1520 patients with grade ≥1 HCC from the National Cancer Database by age: <21 years (children; n = 244) and 21-40 years (young adults; n = 1276).

Disclosures: No source of funding was reported. SJ Commander declared receiving financial support from several sources.

Source: Commander SJ et al. Improved survival and higher rates of surgical resection associated with hepatocellular carcinoma in children as compared to young adults. Int J Cancer. 2022 (Jul 16). Doi: 10.1002/ijc.34215

Recommended Reading

Lenvatinib plus IDADEB-TACE tops lenvatinib monotherapy in advanced HCC
Federal Practitioner
Beta-adrenergic receptor blocker use improves overall survival in HCC
Federal Practitioner
Commentary: HCC With HCV and Treatment Comparisons for Unresectable HCC, August 2022
Federal Practitioner
First-line LEN-TACE: A potential treatment for advanced HCC
Federal Practitioner
Liver Transplant for HCC: Long-term outcome of downstaging to within Milan criteria support national downstaging policy
Federal Practitioner
Liver Transplant for HCC: Long-term outcome of downstaging to within Milan criteria support national downstaging policy
Federal Practitioner
Alcoholism and ALDH2 rs671 polymorphism in patients with HBV-related cirrhosis necessitate close monitoring for HCC
Federal Practitioner
Advanced HCC with PVTT: Hepatic arterial infusion more effective than transcatheter arterial chemoembolization
Federal Practitioner
HBV-related HCC: Clinical outcomes of patients on anti-PD-1 therapy not compromised by HBV viral load
Federal Practitioner
Recurrent HCC: Adjuvant sorafenib after RFA offers survival benefit over RFA alone
Federal Practitioner